Ebselen protects mice against t cell-dependent, tnf-mediated apoptotic liver injury

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 3, 1998, Pages 1098-1104

  Tiegs, Gisa ^a   Küsters, Sabine ^a   Künstle, Gerard ^b   Hentze, Hannes ^b   Kiemer, Alexandra K ^c   Wendel, Albrecht ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF KONSTANZ   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CONCANAVALIN A; EBSELEN; GLUTATHIONE PEROXIDASE; INTERLEUKIN 10; LIPOXYGENASE; STAPHYLOCOCCUS ENTEROTOXIN B; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; ENTEROTOXIN; ENTEROTOXIN B, STAPHYLOCOCCAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; ORGANOSELENIUM DERIVATIVE; PYRROLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; LIVER INJURY; LIVER TOXICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY BURST; T LYMPHOCYTE; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECT; ENZYME ACTIVATION; IMMUNOLOGY; LIVER; LIVER FAILURE; METABOLISM; PATHOLOGY;

ANIMALS; APOPTOSIS; AZOLES; CASPASES; CONCANAVALIN A; ENTEROTOXINS; ENZYME ACTIVATION; IMMUNOSUPPRESSIVE AGENTS; LIVER; LIVER FAILURE; MICE; MICE, INBRED BALB C; NF-KAPPA B; ORGANOSELENIUM COMPOUNDS; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032253785     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Barsig J, Küsters S, Vogt K, Volk H-D, Tiegs G and Wendel A (1995) Lipopolysaccharide-induced interleukin-10 in mice: Role of endogenous tumor necrosis factor-a. Eur J Immunol 25:2888-2893.
2. Beg AA, Sha WC, Bronson RT, Gosh S and Baltimore D (1995) Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376:167-170.
3. Bhardwaj N, Friedman SM, Cole BC and Nisanian AJ (1992) Dendritic cells are potent antigen- cells for microbial superantigens. J Exp Med 175:267-273.
4. Brüne B, Diewald B and Ullrich V (1991) Ebselen affects calcium homeostasis in human platelets. Biochem Pharmacol 41:1805-1811.
5. Cotgreave LA, Duddy SK, Kass GEN, Thompson D and Moldéus P (1989) Studies on the anti-inflammatory activity of ebselen. Ebselen interferes with granulocyte oxidative burst by dual inhibition of NADPH oxidase and protein kinase C Biochem Pharmacol 38:649-656.
6. Dimmeler S, Brüne B and Ullrich V (1991) Ebselen prevents inositol (1,4,5)trisphosphate binding to its receptor. Biochem Pharmacol 42:1151-1153.
7. Gantner F, Leist M, Jug S, Germann PG, Freudenberg MA and Tiegs G (1995a) Tumor necrosis factor-induced hepatic DNA-fragmentation as an early marker of T cell-dependent liver injury in mice. Gastroenterology 109:166-176.
8. Gantner F, Leist M, Lohse AW, Germann PG and Tiegs G (1995b) Concanavalin A-induced T-cell mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 21:190-198.
9. Gantner F, Leist M, Küsters S, Vogt K, Volk H-D and Tiegs G (1996) T cell stimulus-induced crosstalk between lymphocytes and liver macrophages results in augmented release of tumor necrosis factor. Exp Cell Res 229:137-146.
10. Gantner F, Küsters S, Wendel A, Hatzelmann A, Schudt C and Tiegs G (1997) Protection from T cell-mediated murine liver failure by phosphodiesterase inhib-itors. J Pharmacol Exp Ther 280:53-60.
11. Gao J-X and Issekutz AC (1993) The effect of ebselen on polymorphonuclear leukocyte and lymphocyte migration to inflammatory reactions in rats. Immunopharmacol 25:239-251.
12. Gao J-X and Issekutz AC (1994) The effect of ebselen on T-lymphocyte migration to arthritic joints and dermal inflammatory reactions in the rat. Int J Immunopharmacol 16:279-287.
13. Hussain JJ, Mustafa A, Gallati H, Mowat AP, Mieli-Vergani G and Vergani D (1994 Cellular expression of tumor necrosis factor-a and interferon-y in the liver biopsies of children with chronic liver disease. J Hepatol 21:816-821.
14. Kühn R, Löhler J, Rennick D, Rajewsky K and Müller W (1993) Interleukin-10deficient mice develop chronic enterocolitis. Cell 75:263- 274.
15. Künstle G, Leist M, Uhlig S, Revesz L, Feifei R, MacKenzie A and Wendel A (1997) ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-alpha. Immunol Lett 55:5-10.
16. Küsters S, Gantner F, Künstle G and Tiegs G (1996) Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 111:462-471.
17. Küsters S, Tiegs G, Alexopoulou L, Pasparakis M, Douni E, Künstle G, Bluethmann H, Wendel A, Pfizenmaier K, Kollias G and Grell M (1997) In vivo evidence for a functional role of both TNF receptors and transmembrane TNF in experimental hepatits. Eur J Immunol 27:2870-2875.
18. Leist M, Gantner F, Bohlinger I, German PG, Tiegs G and Wendel A (1994) Murine hepatocyte apoptosis induced in vitro and in vivo by TNFa requires transcriptional arrest. J Immunol 153:1778-1787.
19. Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PG and Wendel A (1995) Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 146:1220-1234.
20. Leist M, Gantner F, Jilg S and Wendel A (1995) Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis and nitrite release. J Immmunol 154:1307-1316.
21. Löhr HF, Schlaak JF, Gerken G, Fleischer B, Dienes H-P and Meyer zum Büschenfelde K-H (1994) Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of diff 3rent etiology. Liver 14:161-166.
22. Löhr HF, Schlaak JF, Lohse AW, Böcher WO, Arenz M, Gerken G and Meyer zum Büschenfelde K-H (1996) Autoreactive CD4+ LKM-specific and anticlonotyoic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis. Hepatolcgy 24:1416-1421.
23. Louis H, Le Moine O, Peny MO, Gulbis B, Nisol F, Goldman M and Deviere J (1997) Hepatoprotective role of interleukin 10 in galactosamine/lipopolysaccharide mov.se liver injury. Gastroenterology 112:935-942.
24. Maiorino M, Roveri A, Coassin M and Ursini F (1988) Kinetic mechanism and substrate specificity of glutathione peroxidase activity of ebselen (PZ 51). Biochem Pharmacol 37:2267-2271.
25. Marrack P, Blackman M, Kushnir E and Kappler J (1990) The toxicity of staphylococcal enterotoxin B in mice is mediated by T cell. J Exp Med 171:455-464.
26. Miethke T, Wahl C, Heeg K, Echtenachter B, Krammer PH and Wagner H (1992; T cell-mediated lethal shock triggered in mice by the superantigen Staphylococcal Enterotoxin B: Critical role of tumor necrosis factor. J Exp Med 175:91-98.
27. Mizuhara H, O'Neill E, Seki N, Ogawa T, Kusunoki C, Otsuka K, Satoh S, Miwa M, Senoh H and Fujiwara H (1994) T cell activation-associated hepatic injury: medi-ation by tumor necrosis factor and protection by interleukin 6. J Exp Med 119: 1529-1537.
28. Müller A, Cadenas E, Graf P and Sies H (1984) A novel biologically active seleroorganic compound-I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (ebselen). (Biochem Pharmacol) 33:3235-3239.
29. Nagaki M, Muto Y, Ohnishi H, Yasuda S, Sano K, Naito T, Maeda T, Yamada T and Moriwaki H (1994) Hepatic injury and lethal shock in galactosamine-sensitized mice induced by the superantigen Staphylococcal enterotoxin B. Gastroenterology 106:450-458.
30. Parry SL, Sebbag M, Feldmann M and Brennan FM (1997) Contact with T cells modulates IL-10 production. Role of T cell membrane TNF-o. J Immunol 158: 3673-3681.
31. Ramakrishnan N, Kalinich JF and McClain DE (1996) Ebselen inhibition of apoptosis by reduction of hydroperoxides. Biochem Pharmacol 51:1443-1451.
32. Rodriguez I, Matsuura K, Ody C, Nagata S and Vassalli P ( 1996) Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against fas-mediated fulminant liver destruction ari death. J Exp Med 184:2067-2072.
33. Safayhi H, Tiegs G and Wendel A (1985) A novel biologically active seleno-organic compound-V. Inhibition by ebselen (PZ 51) of rat peritoneal neutrophil lipoxygenase. Biochem Pharmacol 34:2691-2694.
34. Schewe C, Schewe T and Wendel A (1994) Strong inhibition of mammalian lipoxygenases by the antiinflammatory seleno-organic compound ebselen in the absence of glutathione. Biochem Pharmacol 48:65-74.
35. Schewe T (1995) Molecular actions of ebselen - an antiinflammatory antioxidant. Biochem Pharmacol 26:1153-1169.
36. Tiegs G, Wolter M and Wendel A (1989) Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol 3& 627-631.
37. Tiegs G, Hentschel J and Wendel A ( 1992) T cell-dependent experimental liver injuiy in mice inducible by concanavalin A. J Clin Invest 90:196-203.
38. Tiegs G (1994) Immunotoxicology of host-response-mediated experimental liver in-jury. JHepatol 21:890-903.
39. Wendel A, Fausel M, Safayhi H, Tiegs G and Otter R (1984) A novel biologically active seleno-organic compound-II. Activity of PZ 51 in relation to glutathione peroxidase. Biochem Pharmacol 33:3241-3245.
40. Wendel A and Tiegs G (1986) A novel biologically active seleno-organic compound-VI. Protection by ebselen (PZ 51) against galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol 35:2115-2118.